INTERINDIVIDUAL AND INTRAINDIVIDUAL DIFFERENCES IN ORAL CHLORAMBUCIL PHARMACOKINETICS

被引：19

作者：

HARTVIG, P ^{[1
]}

SIMONSSON, B ^{[1
]}

OBERG, G ^{[1
]}

WALLIN, I ^{[1
]}

EHRSSON, H ^{[1
]}

机构：

[1] KAROLINSKA HOSP,KAROLINSKA PHARM,S-10401 STOCKHOLM 60,SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 35卷 / 05期

关键词：

D O I：

10.1007/BF00558252

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：551 / 554

页数：4

共 11 条

[1] PHARMACOKINETICS AND METABOLISM OF CHLORAMBUCIL IN MAN - PRELIMINARY-REPORT [J].

ALBERTS, DS ;

CHANG, SY ;

CHEN, HSG ;

LARCOM, BJ ;

JONES, SE .

CANCER TREATMENT REVIEWS, 1979, 6 :9-17

[2] EFFECT OF FOOD ON PHARMACOKINETICS OF CHLORAMBUCIL AND ITS MAIN METABOLITE, PHENYLACETIC ACID MUSTARD [J].

EHRSSON, H ;

WALLIN, I ;

SIMONSSON, B ;

HARTVIG, P ;

OBERG, G .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (01) :111-114

[3] PHARMACOKINETICS OF CHLORAMBUCIL IN MAN AFTER ADMINISTRATION OF THE FREE DRUG AND ITS PREDNISOLONE ESTER (PREDNIMUSTINE, LEO-1031) [J].

EHRSSON, H ;

WALLIN, I ;

NILSSON, SO ;

JOHANSSON, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (02) :251-253

[4]

EHRSSON H, 1980, J PHARM SCI, V69, P710, DOI 10.1002/jps.2600690627

[5] COMPARATIVE PHYSICOCHEMICAL PROPERTIES, BIOLOGICAL EFFECTS, AND DISPOSITION IN MICE OF 4 NITROGEN MUSTARDS [J].

GODENECHE, D ;

MADELMONT, JC ;

MOREAU, MF ;

PLAGNE, R ;

MEYNIEL, G .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) :1-9

[6] INHIBITION OF HUMAN-TUMOR CLONOGENICITY BY CHLORAMBUCIL AND ITS METABOLITES [J].

GOODMAN, GE ;

MCLEAN, A ;

ALBERTS, DS ;

CHANG, SY .

BRITISH JOURNAL OF CANCER, 1982, 45 (04) :621-623

[7]

KNOSPE WH, 1974, CANCER, V33, P555, DOI 10.1002/1097-0142(197402)33:2<555::AID-CNCR2820330234>3.0.CO

[8]

2-I

[9] THE METABOLISM OF CHLORAMBUCIL [J].

MCLEAN, A ;

NEWELL, D ;

BAKER, G ;

CONNORS, T .

BIOCHEMICAL PHARMACOLOGY, 1980, 29 (14) :2039-2047

[10]

MCLEAN A, 1979, CANCER TREAT REV, V8, P33

← 1 2 →